STAT

Controversial contraception app approved in U.S. drawing scrutiny overseas

A Swedish regulator is set to release the findings of an investigation into a controversial contraception app, Natural Cycles, which was recently approved in the U.S.

European regulators are ramping up their scrutiny of a controversial app that its backers hail as a side-effect-free alternative to hormonal birth control pills — and which the Food and Drug Administration in the U.S. just cleared last month.

The Swedish Medical Products Agency is set to release the findings of a monthslong investigation into the app, Natural Cycles, as soon as this week. Earlier this year, a spate of women in that country unintended pregnancies after using the app. Separately, the U.K.’s advertising regulator on Aug. 29 that a 2017 Facebook advertisement for Natural Cycles that claimed the

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related Books & Audiobooks